Established 1999
 
8,000 companies from
USA,Canada and India.		  
   
Search over 25,000 News & Earnings Archives    
 

MAP Pharmaceuticals(MAPP)

 
123Jump Rating: - Value Gap   Underwriters: Merrill Lynch & Co.
      Morgan Stanley
Status: Priced  
 
Address: 2400 Bayshore Parkway, Suite 200
 FiledDate: 06/18/2007
  Mountain View,
    
  CA 94043
 Filed Price Range ($): $14.00-16.00
       
Telephone: 650-386-3100 Filed Offer Amount ($ Million): $92.00
       
Fax: Shares Offered (Millions): 5
       
Websites: www.mappharma.com Shares Outstanding (Millions): 19.2
       
Management: Timothy Nelson, Pres./CEO
 IPO Date: 10/04/2007
  Christopher Chai, CFO
    
  Final Offer Price ($): $12.00
       
Industry: Pharmaceuticals Final Offer Size (Millions of Shares): 5.00
       
Employees: 55 Final Offer Amount ($ Million): $60.00
       
Competitors: Pharmaceutical companies
 S-1 Forms:
     
   
       
     
     
     
       
 
- Avoid        - Value Gap        - Short-Term Growth        - Long-Term Growth        - Long-Term Value

Company Links
Executives Products Services
Major Stock Holders   (Prior To Offering)

Name

 Class A
Brookside Capital Partners Fund, L.P. 17.00%
Matthew V. McPherron 17.00%
Pequot Private Equity Fund III, L.P 17.60%
Perseus-Soros Biopharmaceutical Fund, L.P. 26.90%
Steven A. Elms 26.90%

Major Stock Holders  (After Offering)

Name

 Common Stock Class A Class B Class C Class L ADS
Brookside Capital Partners Fund, L.P. 0% 12.40% 0% 0% 0% 0%
Matthew V. McPherron 0% 12.40% 0% 0% 0% 0%
Pequot Private Equity Fund III, L.P 0% 13.30% 0% 0% 0% 0%
Perseus-Soros Biopharmaceutical Fund, L.P. 0% 20.10% 0% 0% 0% 0%
Steven A. Elms 0% 20.10% 0% 0% 0% 0%

Income Data 
Year Revenues Costs Oper Income Taxes Net Income EPS
2004 0.00 9,079,351 -9,079,351 0.00 -8,830,827 -16.06
2005 0.00 16,661,815 -16,661,815 0.00 -16,248,810 -28.75
2006 0.00 26,395,470 -26,395,470 0.00 -25,808,866 -43.11
2007 0.00 15,290,041 -15,290,041 0.00 -15,347,813 -25.11
*As of period ended June 30, 2007

Balance Sheet Data

Year

 Cash Acct Recv. Inventory Total Cur Assets Total Cur Liability PPE Total Assets LT Debt SH Equity
2005 7,158,101 0.00 0.00 7,380,518 3,625,508 1,972,295 9,769,058 0.00 -28,565,876
2006 11,090,800 0.00 0.00 18,189,319 4,931,285 2,852,008 21,624,716 10,061,034 -58,676,680
2007 21,886,875 0.00 0.00 54,771,595 8,757,279 3,127,294 59,437,669 8,088,668 -76,975,111
*As of period ended June 30, 2007

Cash Flow Summary

Year

 Net Cash-Ops Net Cash-Inv Net Cash-Fin Net Change
2004 -7,492,891 -1,697,416 31,449,740 22,259,433
2005 -13,810,081 -1,291,251 0.00 -15,101,332
2006 -24,284,762 -7,785,470 36,002,931 3,932,699
2007 -12,963,356 -26,277,524 50,036,955 10,796,075
*As of period ended June 30, 2007
 
 
350 Fund Managers Interviews - 10-year Annual earnings on 4,600 U.S. companies - 20-quarter Earnings on 3,800 U.S. companies - 3,200 U.S. IPO Prospectuses
- 2,100 Economic data releases from U.S., EU, UK, India, HK and Australia. 10-year Annual reports on 3,500 U.S. companies -
U.S. Earnings Calendar with 4,800 companies - 90,000 10-K reports - 26,000 Global markets news archive - 2,200 Earnings Conference Call Summaries
© 1999-2008 123jump.com. All rights reserved